Literature DB >> 7703399

1,25-dihydroxyvitamin D3 regulates NT-3, NT-4 but not BDNF mRNA in astrocytes.

I Neveu1, P Naveilhan, C Baudet, P Brachet, M Metsis.   

Abstract

The effect of 1,25-dihydroxyvitamin D3 on neurotrophin mRNA expression was studied in primary cultures of astrocytes. In addition to its known effects on NGF expression, 1,25-dihydroxyvitamin D3 was shown to upregulate NT-3 mRNA levels, while NT-4 expression was slightly but significantly downregulated. No effect was observed on BDNF mRNA expression. These data clearly show a differential regulation of the four neurotrophins by 1,25-dihydroxyvitamin D3 in primary cultures of astrocytes and suggest that 1,25-dihydroxyvitamin D3 may participate in the expression of NGF, NT-3 and NT-4 in the central nervous system.

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7703399     DOI： 10.1097/00001756-199412300-00032

Source DB:  PubMed          Journal:  Neuroreport        ISSN： 0959-4965            Impact factor:   1.837


  51 in total

1.  Vitamin D hormone confers neuroprotection in parallel with downregulation of L-type calcium channel expression in hippocampal neurons.

Authors:  L D Brewer; V Thibault; K C Chen; M C Langub; P W Landfield; N M Porter
Journal:  J Neurosci       Date:  2001-01-01       Impact factor: 6.167

2.  Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats.

Authors:  Robyn Balden; Amutha Selvamani; Farida Sohrabji
Journal:  Endocrinology       Date:  2012-03-09       Impact factor: 4.736

3.  Strategies to defeat ketamine-induced neonatal brain injury.

Authors:  C P Turner; S Gutierrez; C Liu; L Miller; J Chou; B Finucane; A Carnes; J Kim; E Shing; T Haddad; A Phillips
Journal:  Neuroscience       Date:  2012-02-23       Impact factor: 3.590

4.  Evoked dopamine overflow is augmented in the striatum of calcitriol treated rats.

Authors:  Wayne A Cass; Laura E Peters; Anita M Fletcher; David M Yurek
Journal:  Neurochem Int       Date:  2011-11-22       Impact factor: 3.921

5.  Calcitriol protection against dopamine loss induced by intracerebroventricular administration of 6-hydroxydopamine.

Authors:  Michael P Smith; Anita Fletcher-Turner; David M Yurek; Wayne A Cass
Journal:  Neurochem Res       Date:  2006-04       Impact factor: 3.996

Review 6.  From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D + all-trans retinoic acid + Temozolomide combination in treatment of GBM.

Authors:  Ilhan Elmaci; Aysel Ozpinar; Alp Ozpinar; Jennifer L Perez; Meric A Altinoz
Journal:  Metab Brain Dis       Date:  2019-04-01       Impact factor: 3.584

7.  Calcitriol promotes augmented dopamine release in the lesioned striatum of 6-hydroxydopamine treated rats.

Authors:  Wayne A Cass; Laura E Peters; Anita M Fletcher; David M Yurek
Journal:  Neurochem Res       Date:  2014-05-25       Impact factor: 3.996

8.  Vitamin D status and functional performance in peripheral artery disease.

Authors:  Mary M McDermott; Kiang Liu; Luigi Ferrucci; Lu Tian; Jack Guralnik; Peter Kopp; Huimin Tao; Linda Van Horn; Yihua Liao; David Green; Melina Kibbe; Michael H Criqui
Journal:  Vasc Med       Date:  2012-07-19       Impact factor: 3.239

9.  25-Hydroxyvitamin D, dementia, and cerebrovascular pathology in elders receiving home services.

Authors:  J S Buell; B Dawson-Hughes; T M Scott; D E Weiner; G E Dallal; W Q Qui; P Bergethon; I H Rosenberg; M F Folstein; S Patz; R A Bhadelia; K L Tucker
Journal:  Neurology       Date:  2009-11-25       Impact factor: 9.910

Review 10.  Vitamin D and human health: lessons from vitamin D receptor null mice.

Authors:  Roger Bouillon; Geert Carmeliet; Lieve Verlinden; Evelyne van Etten; Annemieke Verstuyf; Hilary F Luderer; Liesbet Lieben; Chantal Mathieu; Marie Demay
Journal:  Endocr Rev       Date:  2008-08-11       Impact factor: 19.871
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.